Alopecia: Absence of hair from areas where it is normally present.Alopecia Areata: Loss of scalp and body hair involving microscopically inflammatory patchy areas.Scalp: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL).Hair Follicle: A tube-like invagination of the EPIDERMIS from which the hair shaft develops and into which SEBACEOUS GLANDS open. The hair follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from the dermis. (Stedman, 26th ed) Follicles of very long hairs extend into the subcutaneous layer of tissue under the SKIN.Hair: A filament-like structure consisting of a shaft which projects to the surface of the SKIN from a root which is softer than the shaft and lodges in the cavity of a HAIR FOLLICLE. It is found on most surfaces of the body.Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)Scalp DermatosesFolliculitis: Inflammation of follicles, primarily hair follicles.Dermoscopy: A noninvasive technique that enables direct microscopic examination of the surface and architecture of the SKIN.Tinea Capitis: Ringworm of the scalp and associated hair mainly caused by species of MICROSPORUM; TRICHOPHYTON; and EPIDERMOPHYTON, which may occasionally involve the eyebrows and eyelashes.Trichotillomania: Compulsion to pull out one's hair.Cicatrix: The fibrous tissue that replaces normal tissue during the process of WOUND HEALING.Photophobia: Abnormal sensitivity to light. This may occur as a manifestation of EYE DISEASES; MIGRAINE; SUBARACHNOID HEMORRHAGE; MENINGITIS; and other disorders. Photophobia may also occur in association with DEPRESSION and other MENTAL DISORDERS.Lichen Planus: An inflammatory, pruritic disease of the skin and mucous membranes, which can be either generalized or localized. It is characterized by distinctive purplish, flat-topped papules having a predilection for the trunk and flexor surfaces. The lesions may be discrete or coalesce to form plaques. Histologically, there is a "saw-tooth" pattern of epidermal hyperplasia and vacuolar alteration of the basal layer of the epidermis along with an intense upper dermal inflammatory infiltrate composed predominantly of T-cells. Etiology is unknown.Eyebrows: Curved rows of HAIR located on the upper edges of the eye sockets.Triethylenephosphoramide: An insect chemosterilant and an antineoplastic agent.Hypotrichosis: Presence of less than the normal amount of hair. (Dorland, 27th ed)Skin: The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.Ichthyosis: Any of several generalized skin disorders characterized by dryness, roughness, and scaliness, due to hypertrophy of the stratum corneum epidermis. Most are genetic, but some are acquired, developing in association with other systemic disease or genetic syndrome.Sebaceous Glands: Small, sacculated organs found within the DERMIS. Each gland has a single duct that emerges from a cluster of oval alveoli. Each alveolus consists of a transparent BASEMENT MEMBRANE enclosing epithelial cells. The ducts from most sebaceous glands open into a HAIR FOLLICLE, but some open on the general surface of the SKIN. Sebaceous glands secrete SEBUM.Mucinosis, Follicular: A disease of the pilosebaceous unit, presenting clinically as grouped follicular papules or plaques with associated hair loss. It is caused by mucinous infiltration of tissues, and usually involving the scalp, face, and neck. It may be primary (idiopathic) or secondary to mycosis fungoides or reticulosis.Mucinoses: Mucoid states characterized by the elevated deposition and accumulation of mucin (mucopolysaccharides) in dermal tissue. The fibroblasts are responsible for the production of acid mucopolysaccharides (GLYCOSAMINOGLYCANS) in the ground substance of the connective tissue system. When fibroblasts produce abnormally large quantities of mucopolysaccharides as hyaluronic acid, chondroitin sulfate, or heparin, they accumulate in large amounts in the dermis.Encyclopedias as Topic: Works containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. (From The ALA Glossary of Library and Information Science, 1983)Mycosis Fungoides: A chronic, malignant T-cell lymphoma of the skin. In the late stages, the LYMPH NODES and viscera are affected.Facial DermatosesFluocinonide: A topical glucocorticoid used in the treatment of ECZEMA.Clobetasol: A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE, it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression.Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.Coal Tar: A by-product of the destructive distillation of coal used as a topical antieczematic. It is an antipruritic and keratoplastic agent used also in the treatment of psoriasis and other skin conditions. Occupational exposure to soots, tars, and certain mineral oils is known to be carcinogenic according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985) (Merck Index, 11th ed).DelawareBeauty: Characteristics or attributes of persons or things which elicit pleasurable feelings.Leadership: The function of directing or controlling the actions or attitudes of an individual or group with more or less willing acquiescence of the followers.Crowns: A prosthetic restoration that reproduces the entire surface anatomy of the visible natural crown of a tooth. It may be partial (covering three or more surfaces of a tooth) or complete (covering all surfaces). It is made of gold or other metal, porcelain, or resin.Awards and PrizesPets: Animals kept by humans for companionship and enjoyment, as opposed to DOMESTIC ANIMALS such as livestock or farm animals, which are kept for economic reasons.Animals, Domestic: Animals which have become adapted through breeding in captivity to a life intimately associated with humans. They include animals domesticated by humans to live and breed in a tame condition on farms or ranches for economic reasons, including LIVESTOCK (specifically CATTLE; SHEEP; HORSES; etc.), POULTRY; and those raised or kept for pleasure and companionship, e.g., PETS; or specifically DOGS; CATS; etc.Head: The upper part of the human body, or the front or upper part of the body of an animal, typically separated from the rest of the body by a neck, and containing the brain, mouth, and sense organs.Crowdsourcing: Social media model for enabling public involvement and recruitment in participation. Use of social media to collect feedback and recruit volunteer subjects.Electronic Mail: Messages between computer users via COMPUTER COMMUNICATION NETWORKS. This feature duplicates most of the features of paper mail, such as forwarding, multiple copies, and attachments of images and other file types, but with a speed advantage. The term also refers to an individual message sent in this way.Food Dispensers, Automatic: Mechanical food dispensing machines.Editorial Policies: The guidelines and policy statements set forth by the editor(s) or editorial board of a publication.Authorship: The profession of writing. Also the identity of the writer as the creator of a literary production.Periodicals as Topic: A publication issued at stated, more or less regular, intervals.Postal Service: The functions and activities carried out by the U.S. Postal Service, foreign postal services, and private postal services such as Federal Express.Internet: A loose confederation of computer communication networks around the world. The networks that make up the Internet are connected through several backbone networks. The Internet grew out of the US Government ARPAnet project and was designed to facilitate information exchange.Dictionaries, MedicalDictionaries as Topic: Lists of words, usually in alphabetical order, giving information about form, pronunciation, etymology, grammar, and meaning.Terminology as Topic: The terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area.Dictionaries, ChemicalSongbirds: PASSERIFORMES of the suborder, Oscines, in which the flexor tendons of the toes are separate, and the lower syrinx has 4 to 9 pairs of tensor muscles inserted at both ends of the tracheal half rings. They include many commonly recognized birds such as CROWS; FINCHES; robins; SPARROWS; and SWALLOWS.Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.

Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. (1/646)

PURPOSE: Both paclitaxel and cisplatin have moderate activity in patients with metastatic or recurrent cancer of the cervix, and the combination of these two agents has shown activity and possible synergism in a variety of solid tumors. We administered this combination to patients with metastatic or recurrent cervical cancer to evaluate its activity. PATIENTS AND METHODS: Thirty-four consecutive patients were treated on an outpatient basis with paclitaxel 175 mg/m2 administered intravenously over a 3-hour period followed by cisplatin 75 mg/m2 administered intravenously with granulocyte colony-stimulating factor support. The chemotherapy was administered every 3 weeks for a maximum of six courses. RESULTS: Sixteen patients (47%; 95% confidence interval, 30% to 65%) achieved an objective response, including five complete responses and 11 partial responses. Responses occurred in 28% of patients with disease within the radiation field only and in 57% of patients with disease involving other sites. The median duration of response was 5.5 months, and the median times to progression and survival for all patients were 5 and 9 months, respectively. Grade 3 or 4 toxicities included anemia in 18% of patients and granulocytopenia in 15% of patients. Fifty-three percent of patients developed some degree of neurotoxicity; 21% of cases were grade 2 or worse. CONCLUSION: The combination of paclitaxel with cisplatin seems relatively well tolerated and moderately active in patients with metastatic or recurrent cervical cancer. The significant incidence of neurotoxicity is of concern, and alternative methods of administration of the two agents could be evaluated. Then, further study of this combination, alone or with the addition of other active agents, is warranted.  (+info)

Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer. (2/646)

PURPOSE: Platinum-based chemotherapy currently represents standard treatment for advanced non-small-cell lung cancer. Gemcitabine is one of the most interesting agents currently in use in advanced non-small-cell lung cancer, and high response rates have been reported when it is administered in combination with cisplatin. The aim of the present study was to evaluate the combination of gemcitabine and carboplatin in a phase I-II study. PATIENTS AND METHODS: Chemotherapy-naive patients with stage IIIB-IV non-small-cell lung cancer received carboplatin at area under the concentration-time curve (AUC) 5 mg/mL/min and gemcitabine at an initial dose of 800 mg/m2, subsequently escalated by 100 mg/m2 per step. Gemcitabine was administered on days 1 and 8 and carboplatin on day 8 of the 28-day cycle. Dose escalation proceeded up to dose-limiting toxicity (DLT), which was defined as grade 4 neutropenia or thrombocytopenia or grade 3 nonhematologic toxicity. RESULTS: Neutropenia was DLT, inasmuch as it occurred in three of five patients receiving gemcitabine 1,200 mg/m2. Nonhematologic toxicities were mild. Gemcitabine 1,100 mg/m2 plus carboplatin AUC 5 was recommended for phase II studies. An objective response was observed in 13 (50%) of 26 patients, including four complete responses (15%) and nine partial responses (35%). Median duration of response was 13 months (range, 3 to 23 months). Median overall survival was 16 months (range, 3 to 26 months). CONCLUSION: The combination of gemcitabine and carboplatin is well tolerated and active. Neutropenia was DLT. The observed activity matches that observable in cisplatin-gemcitabine studies, whereas duration of response and survival are even higher. A phase II trial is under way.  (+info)

Longevity, stress response, and cancer in aging telomerase-deficient mice. (3/646)

Telomere maintenance is thought to play a role in signaling cellular senescence; however, a link with organismal aging processes has not been established. The telomerase null mouse provides an opportunity to understand the effects associated with critical telomere shortening at the organismal level. We studied a variety of physiological processes in an aging cohort of mTR-/- mice. Loss of telomere function did not elicit a full spectrum of classical pathophysiological symptoms of aging. However, age-dependent telomere shortening and accompanying genetic instability were associated with shortened life span as well as a reduced capacity to respond to stresses such as wound healing and hematopoietic ablation. In addition, we found an increased incidence of spontaneous malignancies. These findings demonstrate a critical role for telomere length in the overall fitness, reserve, and well being of the aging organism.  (+info)

Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group. (4/646)

Leukemic patients receiving marrow from HLA-identical sibling donors were randomized to treatment with either busulfan 16 mg/kg (n = 88) or total body irradiation ([TBI] n = 79) in addition to cyclophosphamide 120 mg/kg. The patients were observed for a period of 5 to 9 years. Busulfan-treated patients had an increased risk of veno-occlusive disease (VOD) of the liver (12% v 1%, P =.01) and hemorrhagic cystitis (32% v 10%, P =.003). Acute graft-versus-host disease (GVHD) was similar in the two groups, but the 7-year cumulative incidence of chronic GVHD was 59% in the busulfan-treated group versus 47% in the TBI group (P =.05). Death from GVHD was more common in the busulfan group (22% v 3%, P <.001). Obstructive bronchiolitis occurred in 26% of the busulfan patients but in only 5% of the TBI patients (P <.01). Complete alopecia developed in 8 busulfan patients and partial alopecia in 17, versus five with partial alopecia in the TBI group (P <.001). Cataracts occurred in 5 busulfan-treated patients and 16 TBI patients (P =.02). The incidence of relapse after 7 years was 29% in both groups. Seven-year transplant-related mortality (TRM) in patients with early disease was 21% in the busulfan group and 12% in the TBI group. In patients with more advanced disease, the corresponding figures were 64% and 22%, respectively (P =.004). Leukemia-free survival (LFS) in patients with early disease was 68% in busulfan-treated patients and 66% in TBI patients. However, 7-year LFS in patients with more advanced disease was 17% in the busulfan group versus 49% in the TBI group (P <.01). In patients with chronic myeloid leukemia (CML) in first chronic phase, 7-year LFS was 72% and 83% in the two groups, respectively.  (+info)

Clomipramine-induced urinary retention in a cat. (5/646)

A 10-year-old, female, spayed shorthair with presumed psychogenic alopecia was treated with clomipramine (1 mg/kg body weight/day). The cat developed urinary retention within 2 days. Clomipramine was discontinued. Clinical signs resolved over the next 7 days. The urinary retention was attributed to the anticholinergic effects of clomipramine.  (+info)

Identification of a genetic defect in the hairless gene in atrichia with papular lesions: evidence for phenotypic heterogeneity among inherited atrichias. (6/646)

Recently, we showed that atrichia with papular lesions (APL), a rare inherited form of alopecia, is transmitted as an autosomal recessive trait in a large inbred kindred of Israeli-Arab origin. Furthermore, we mapped the APL locus to a 5-cM region of chromosome 8p12 in this family. The human "hairless" gene is a candidate target gene for the disease mutation because it maps to the APL locus and because it was recently found to be mutated in a related but clinically distinct form of alopecia known as "alopecia universalis" or "congenital alopecia." In the present study, the coding sequence of the hairless gene was compared by reverse transcription-PCR in fibroblast cell lines derived from an affected patient and an unrelated individual. We identified a single-base deletion (3434delC) in the hairless gene that cosegregated with the disease phenotype in the family. This deletion is predicted to cause a frameshift mutation in the highly conserved C-terminal part of the hairless protein, a region putatively involved in the transcription factor activity of the hairless gene product. The present results are indicative of phenotypic heterogeneity in inherited atrichias caused by mutations in the hairless gene, suggesting different roles for the regions mutated in APL and in other forms of congenital atrichia during hair development.  (+info)

Medical treatments for balding in men. (7/646)

Two drugs are available for the treatment of balding in men. Minoxidil, a topical product, is available without a prescription in two strengths. Finasteride is a prescription drug taken orally once daily. Both agents are modestly effective in maintaining (and sometimes regrowing) hair that is lost as a result of androgenic alopecia. The vertex of the scalp is the area that is most likely to respond to treatment, with little or no hair regrowth occurring on the anterior scalp or at the hairline. Side effects of these medications are minimal, making them suitable treatments for this benign but psychologically disruptive condition.  (+info)

Insulin gene polymorphism and premature male pattern baldness in the general population. (8/646)

Insulin is found in hair follicles and may play a role in the regulation of androgen metabolism and the hair growth cycle, which are relevant to the loss of scalp hair known as male pattern baldness. An excess of dihydrotestosterone on balding scalp indicates that the condition is androgen dependent. Premature male pattern baldness may be the male phenotype of familial polycystic ovary syndrome, a condition characterized by high levels of androgens and insulin that has been linked to insulin gene polymorphism. Therefore, we studied possible associations between relevant insulin gene polymorphisms and premature male pattern baldness in the general community. We examined the distribution of three dimorphic restriction fragment length polymorphisms: HphI, PstI and FokI in cases consisting of 56 men aged 18-30 years with significant baldness, and in 107 control men aged 50 years or more with no indication of baldness. No significant differences between cases and controls in allele, genotype or haplotype frequencies were identified. We conclude that, in the general population, the insulin gene is not associated with premature male pattern baldness.  (+info)

male baldness, male pattern baldness, male pattern baldness genetics, male pattern baldness cure, male pattern baldness remedy, male baldness medication
FEMALE PATTERN HAIR LOSS (ANDROGENETIC ALOPECIA). What are the aims of this leaflet?. This leaflet has been written to help you understand more about female pattern hair loss (FPHL). It tells you what it is, what causes it, what it looks like, how it is diagnosed, what treatments are available, and where you can get more information about it.. What is female pattern hair loss?. Female pattern hair loss (FPHL) has also been called androgenetic alopecia. It is the most common type of alopecia (hair loss) in women and the severity can vary.. What causes female pattern hair loss?. FPHL is caused by a combination of genetic and hormonal factors. The hairs produced by the affected follicles become progressively smaller in diameter, shorter in length and lighter in colour until eventually the follicles shrink completely and stop producing hair. FPHL can be associated with conditions in which androgen (a group of hormones) levels are elevated such as polycystic ovarian syndrome (PCOS). Acne, increased ...
Balding in men with a typical pattern is commonly known as male pattern baldness. It is also known as androgenic alopecia because it is related to androgen hormones.
Researchers from the Perelman School of Medicine at the University of Pennsylvania have identified an abnormal amount a protein called Prostaglandin D2 in the bald scalp of men with male pattern baldness, a discovery that may lead directly to new treatments for the most common cause of hair loss in men. In both human and animal models, researchers found that a prostaglandin known as PGD2 and its derivative, 15-dPGJ2, inhibit hair growth. The PGD2-related inhibition occurred through a receptor called GPR44, which is a promising therapeutic target for androgenetic alopecia in both men and women with hair loss and thinning.. Male pattern baldness strikes 8 of 10 men under 70 years old, and causes hair follicles to shrink and produce microscopic hairs, which grow for a shorter duration of time than normal follicles.. Researchers took an unbiased approach when scanning for potential biological causes of baldness, looking in scalp tissue from balding and non-bald spots from men with male pattern ...
What is male pattern baldness? Male pattern baldness, Androgenic alopecia in men is hereditary hair loss condition - Dallas TX expert.
Male pattern baldness effects 70% of men in their lifetime. To find out more about male pattern baldness and the Hamilton Norwood chart visit 121doc
... or male or female pattern baldness:. Male Pattern Baldness:. More than 95% of hair thinning in men is defined as male pattern baldness, or androgenetic alopecia. Male pattern baldness is characterized by hair receding from the lateral sides of the forehead (known as a "receding hairline") and/or a thinning crown (balding to the area known as the vertex. Both become more pronounced until they eventually meet, leaving a horseshoe-shaped ring of hair around the back of the head. The trigger for this type of baldness is DHT, a powerful sex hormone, body- and facial-hair growth promoter that can adversely affect the prostate as well as the hair located on the head. The mechanism by which DHT accomplishes this is not yet fully understood. In genetically-prone scalps, i.e. those experiencing male or female pattern baldness, DHT initiates a process of follicular miniaturization, in which the hair follicle begins to deteriorate. As a consequence, the hairs growth phase (anagen) is ...
Question - Acne, unwanted hair growth, male pattern baldness. Prescribed pregnistar. History of PCOS. Suggestions?. Ask a Doctor about diagnosis, treatment and medication for Male pattern baldness, Ask an OBGYN, Gynecologic Oncology
Treatment for Male Pattern Baldness prices from $199 - Enquire for a fast quote. Free consultation. Choose from 7 Treatment for Male Pattern Baldness Clinics in Singapore ★ find the best one for you. Customer Service Award Winners 2018.
Visual Impromptu Hair Replacements for Mens and Womens Hair Loss from Alopecia Areata, male pattern baldness, female hair loss, or thinning hair. Hair Replacement Systems, including the VRHairline or the SkinFlex .
Visual Impromptu Hair Replacements for Mens and Womens Hair Loss from Alopecia Areata, male pattern baldness, female hair loss, or thinning hair. Hair Replacement Systems, including the VRHairline or the SkinFlex .
Synonyms for androgenetic alopecia in Free Thesaurus. Antonyms for androgenetic alopecia. 1 synonym for male pattern baldness: male-patterned baldness. What are synonyms for androgenetic alopecia?
What are the best Male Patter Baldness Treatments in 2018? Here are Natural and Scientific ways to cure Male Pattern Baldness or Androgenic Alopecia for this
Many scientists believe that the appropriate dosage of hair vitamins may stop and reverse guy pattern baldness, or MPB. MPB is the man variation of the type of hair reduction well-known as androgenic alopecia. It has been determined that androgenic alopecia counts for 95% of all hair reduction in guys.. The idea that man pattern baldness is countered with all the appropriate hair vitamins is hopeful information indeed for millions of males, because despite the traditional wisdom the wide most of males detest losing their hair as a result of MPB and discover it to be emotionally truly painful. While it is actually true that some males happen to be thus appealing in different methods, or because they happen to have looks that fit hand-in-glove with balding, that they dont care about losing their hair as they age, they are just a really little minority of guys.. Most guys are not the good-looking stars or dont fit the image of the recognized aging genius novelist that are portrayed in the media ...
Male Pattern Baldness is the most common cause of hair loss. Learn more about hair loss and the hair restoration treatments Apollo offers.
Androgenic alopecia can occur in both males and females however male pattern baldness is associated with the development of this condition in males.
Get to know the most common & other symptoms of male pattern baldness. Also get to know the stages for hair loss for men only at Dr Batras™. Talk to our experts now!
Androgenetic alopecia is a type of hair loss that is acquired genetically and it affects both men and women. This is what is commonly called male or female pattern baldness. This more prevalent in men, but it is much more devastating when it affects women.. If you have seen some middle aged men sporting a receding hairline, that is a classic example of male pattern baldness. A hairline that goes backward forming a "U" or "W" shape, or balding that starts from the crown area best characterize this type of hair loss. In women it presents as a thinning or balding along the hairline that runs in the middle of the head. Sometimes it is also a diffuse thinning and shedding of hairs all over the scalp. It is a gradual process but hair sheds excessively and never goes back.. Androgenetic alopecia is an autoimmune condition in which your body attacks your own hairs. The main factor that is at play here is the male hormone androgen. Maybe you are raising your eyebrows at this point thinking that you are a ...
According to an article published by CBS News, men with male pattern baldness may have a higher risk of developing aggressive prostate cancer. A study published in the Journal of Clinical Oncology shows that the baldness develops after cumulative, lifelong exposure to cutaneous testosterone. While the testosterone in the skin is not necessarily...
Finasteride 1mg price india / finasteride dosage for male pattern baldness / buy finasteride online cheap / quanto costa finasteride 1mg : The hair loss of nutrients is only looking at bedtime, you can develop.
Male pattern baldness affects half the world male population. To learn more about your hair loss treatment options, schedule a consultation today.
The Norwood scale is a system of classification for the stages of male pattern baldness. Read this article to learn about the stages of the Norwood scale and how it can help the treatment of hair loss....
It all started when Derrick Hawthorne was 18 years old.Just a bit in front at first, then more and more until he was left with a ring of hair around the equator, creating a look he calls the Caesar. I went from a full head of hair to none, Hawthorne said.Over the next few years, he came to terms with what nature had in mind for his hair. Now, at 28, the Columbus, Ohio resident shaves his head clean and wears a full red beard.Male pattern baldness can be traumatic for men.
When you lose your hair, the way you perceive yourself can change drastically. In addition it can also change the way others react to you in different aspects of your life. Because of this some people experience male pattern baldness depression. This article explores a number of different ways of treating MPB depression.
Local resource for mens health experts in Leesville, LA. Includes detailed information on local businesses that provide access to treatment for heart disease, male pattern baldness, benign enlargement of prostate, erectile dysfunction, prostate cancer, and lung cancer, as well as advice and content on mens skin care.
Local resource for mens health experts in Prineville, OR. Includes detailed information on local businesses that provide access to treatment for heart disease, male pattern baldness, benign enlargement of prostate, erectile dysfunction, prostate cancer, and lung cancer, as well as advice and content on mens skin care.
Female pattern hair loss is alopecia that occurs in a diffuse pattern with no distinctive or predictable trait of the sporadic hair loss nature of the condition. Minoxidil and finasteride are the two FDA approved medications for female pattern hair loss. The former comes in solution form that is applied twice per day on affected scalp. Minoxidil encourages hair growth in treated areas through promoting blood circulation and consequently oxygen and nutrition levels. Finasteride, on the other hand, is a pill that hamstrings the enzymatic of 5-alpha-reductase, a protein that catalyzes the conversion of testosterone to the more aggressive version DHT.. Male pattern hair loss, possesses polar opposite traits. Androgen alopecia in male pattern hair loss occurs in the notorious M or U shaped pattern. The remaining hair, usually located closer to the back of the scalp, are adapted with androgen resistant follicular units. The treatments for male pattern hair loss vary in accordance to the progression of ...
Hair loss typically occurs with aging, and is slightly more common in men than in women. But it can also happen for other reasons, such as after major surgery, after childbirth or due to another physical or psychological form of stress. It can also be attributed to underlying diseases such as lupus and iron deficiency, because of a hormonal imbalance or with the use of certain medications.. Male pattern baldness - Known as androgenetic alopecia, this condition is marked by a receding front hairline and hair loss at the top of the head. It is believed to be related to genetic makeup and hormone levels. Male pattern baldness affects about 50 per cent of men. It can start as early as in ones teen years. Four out of five men will have some degree of baldness by age 70.. Female pattern baldness (also known as androgenetic alopecia) usually involves thinning of hair on the top, or the "crown" of the scalp. About 40 per cent of women experience some signs of thinning hair by age 50. Genetics is ...
What are the aims of this leaflet?. This leaflet has been written to help you understand more about androgenetic alopecia. It tells you what androgenetic alopecia is, what causes it, what it looks like, how it is diagnosed, what treatments are available, and where you can get more information about it.. What is androgenetic alopecia?. Androgenetic alopecia is the most common type of progressive hair loss. It is also known as male-pattern baldness, female-pattern baldness, or just common baldness. It affects about 50% of men over the age of 50, and about 50% of women over the age of 65. In women the severity varies, it may present as widespread hair thinning but in some cases it can lead to complete baldness.. What causes androgenetic alopecia?. Androgenetic alopecia is caused by a combination of genetic and hormonal factors. Dihydrotestosterone (DHT) is the main hormone responsible for androgenetic alopecia in genetically susceptible individuals. DHT causes scalp hair loss by inducing a change ...
First, Androgenetic, consisting of ANDROGEN (Any of the various hormones that control the appearance and development of masculine characteristics such as testosterone). And GENETIC-the inheritance of genes from either the mother or the fathers side of the family. Add AGE, which when coupled with genetics, represents a time clock that will signal the hair follicle to produce an enzyme named 5 alpha reductase.. When the testosterone present in the follicle combines with the enzyme 5 alpha reductase, it produces dihydrotestosterone (DHT). Hair follicle receptors are sensitive to DHT and thereby start the process of male or female pattern hair loss.. Second, ALOPECIA meaning hair loss, of which there are many types.. Put simply, scientists are working against aging, hormones and genetics. This is no easy task. Add the fact that male or female pattern hair loss is not life threatening, and it is easy to see why many physicians do not view hair loss as a priority in scientific research.. What is ...
Male pattern hair loss is a medical condition that affects more than 50% of men. Learn about what causes androgenetic alopecia and available treatments.
Objectives: To test the hypothesis that adult males with classic form of Fabry disease have a significantly lower incidence of androgenic alopecia than matched controls.. Study Population: 120 patients aged 20-64 with Fabry disease that have GLA mutations or alpha-galactosidase A activity associated with no residual enzyme activity and non-Fabry male controls of the same age range and the same number of non-Fabry controls.. Design: This is a cross-sectional study comparing the prevalence of androgenic alopecia in two groups of subjects.. Outcome Measures: The levels of the outcome will be no androgenic alopecia and frontal only androgenetic alopecia opposed to vertex only and frontal and vertex androgenetic alopecia. ...
Objectives: To test the hypothesis that adult males with classic form of Fabry disease have a significantly lower incidence of androgenic alopecia than matched controls.. Study Population: 120 patients aged 20-64 with Fabry disease that have GLA mutations or alpha-galactosidase A activity associated with no residual enzyme activity and non-Fabry male controls of the same age range and the same number of non-Fabry controls.. Design: This is a cross-sectional study comparing the prevalence of androgenic alopecia in two groups of subjects.. Outcome Measures: The levels of the outcome will be no androgenic alopecia and frontal only androgenetic alopecia opposed to vertex only and frontal and vertex androgenetic alopecia. ...
TY - JOUR. T1 - Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia. AU - Bichsel, Kyle J.. AU - Gogia, Navdeep. AU - Malouff, Timothy. AU - Pena, Zachary. AU - Forney, Eric. AU - Hammiller, Brianna. AU - Watson, Patrice. AU - Hansen, Laura A.. PY - 2013/7/19. Y1 - 2013/7/19. N2 - Treatment of cancer patients with chemotherapeutics like cyclophosphamide often causes alopecia as a result of premature and aberrant catagen. Because the epidermal growth factor receptor (EGFR) signals anagen hair follicles to enter catagen, we hypothesized that EGFR signaling may be involved in cyclophosphamide-induced alopecia. To test this hypothesis, skin-targeted Egfr mutant mice were generated by crossing floxed Egfr and Keratin 14 promoter-driven Cre recombinase mice. Cyclophosphamide treatment of control mice resulted in alopecia while Egfr mutant skin was resistant to cyclophosphamide-induced alopecia. Egfr mutant skin entered catagen normally, as indicated by dermal papilla ...
This is an inherited pattern of hair loss and it is the most common cause of permanent hair loss in both women and men. Androgenetic alopecia in men is what is known as male pattern baldness -hair loss that starts at the front of the scalp and recedes backward over time, and hair in the center of the scalp thins and falls out. In women, this results in uniform hair thinning. Androgenetic alopecia is genetically linked hair thinning. Hair loss typically begins between the ages of 12 and 40. Androgenetic alopecia usually doesnt cause menstrual issues or interfere with pregnancy or endocrine function.. 2. ALOPECIA AREATA:. Alopecia areata is an immune disease that affects almost 1% of the population. This type of hair loss appears in various degrees of severity- from small, round patches of hair loss that re-grow without medical treatment, to chronic, extensive hair loss that can involve the loss of all hair on the scalp or body. This type of hair loss affects both genders equally and can occur at ...
Results will be published in the November 2013 issue of Alcoholism: Clinical & Experimental Research and are currently available at Early View.. "Finasteride is a synthetic medication used to treat enlarged prostates in older men," explained Michael S. Irwig, assistant professor of medicine at The George Washington University and sole author of the study. "It is also used by younger men for male pattern baldness. In younger men with male pattern baldness, [less than] five percent have developed sexual side effects. Finasteride has not been used for alcohol reduction in humans; our study is among the first to look at its effects on drinking in humans.". "Finasteride is a 5α-reductase inhibitor that blocks the production of a variety of cholesterol-derived hormones and modulators, including certain androgens and other steroids that are active in both the body and brain," explained Chuck Zorumski, the Samuel B. Guze Professor and head of psychiatry at Washington University School of Medicine. ...
Alopecia, Androgenetic Alopecia Treatment of Alternative Alopecia Medicine Treatment, Alternative Androgenetic Alopecia Medicine Treatment on Alopecia Treatment Medical Center Alopecia Remedies
TY - JOUR. T1 - Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model. AU - Katikaneni, Ranjitha. AU - Ponnapakkam, Tulasi. AU - Matsushita, Osamu. AU - Sakon, Joshua. AU - Gensure, Robert. PY - 2014/1/1. Y1 - 2014/1/1. N2 - Alopecia is a psychologically devastating complication of chemotherapy for which there is currently no effective therapy. PTH-CBD is a collagen-targeted parathyroid hormone analog that has shown promise as a therapy for alopecia disorders. This study compared the efficacy of prophylactic versus therapeutic administration of PTH-CBD in chemotherapy-induced alopecia using a mouse model that mimics the cyclic chemotherapy dosing used clinically. C57BL/6J mice were treated with a single subcutaneous injection of PTH-CBD (320 mcg/kg) or vehicle control before or after hair loss developing from three courses of cyclophosphamide chemotherapy (50-150 mg/kg/week). Mice receiving ...
Last year, by far the biggest news of the year involved two likely cures for alopecia areata (AA) in humans. One was the arthritis drug tocafitinib and the other was the cancer drug ruxolitinib. Both drugs are classified as Janus kinase (JAK) inhibitors, and it is likely that many other drugs from this family will lead to similar results when it comes to hair regrowth. If you read my two main posts on this subject from last year (see here and here), it should be quite obvious how exciting the news was based on the large-scale global media coverage at the time (and of course the miraculous before and after human scalp photos instead of the usual mice photos).. Unfortunately, the vast majority of men (and many women too) who have hair loss suffer from androgenic alopecia, also known as male pattern baldness (MPB). There are probably 100 times as many people who suffer from MPB as there are who suffer from alopecia areata. So the big news of last year was only useful to 1 percent of hair loss ...
Last year, by far the biggest news of the year involved two likely cures for alopecia areata (AA) in humans. One was the arthritis drug tocafitinib and the other was the cancer drug ruxolitinib. Both drugs are classified as Janus kinase (JAK) inhibitors, and it is likely that many other drugs from this family will lead to similar results when it comes to hair regrowth. If you read my two main posts on this subject from last year (see here and here), it should be quite obvious how exciting the news was based on the large-scale global media coverage at the time (and of course the miraculous before and after human scalp photos instead of the usual mice photos).. Unfortunately, the vast majority of men (and many women too) who have hair loss suffer from androgenic alopecia, also known as male pattern baldness (MPB). There are probably 100 times as many people who suffer from MPB as there are who suffer from alopecia areata. So the big news of last year was only useful to 1 percent of hair loss ...
Understanding the cause. There are a number of different causes of hair loss and before you start looking around for ways to address the problem, its important that understand the trigger in your particular case.. The most common type of hair loss is male pattern baldness. Around half of men experience this by the time they reach the age of 50 and it is characterised by a receding hairline and thinning hair at the temples and on top of the head. Male pattern baldness is thought to run in families. The problem can also affect women. Female pattern baldness usually results in a thinning of hair on the top of the head and it often gets worse after the menopause.. Another type of hair loss is referred to as telogen effluvium. This typically occurs after a stressful physical event such as childbirth, major surgery or sudden weight loss. It can also be triggered by illnesses or certain medications. Fortunately in these cases, hair tends to grow back after a few months.. Hair loss can be caused by ...
A new report by Report Ocean asserts that the global alopecia treatment market is witnessing significant growth due to increasing cases of baldness among men and women across the world. The report is tiltled as "Global Alopecia Treatment Market Size study, by Disease Type (Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia, Others), by End-use (Homecare Settings, Dermatology Clinics), by Sales Channel (Prescriptions, OTC), by Gender (Male, Female) and Regional Forecasts 2020-2027.". The report further states that the global alopecia treatment market stood at US$2.6 bn in 2019. It is projected to propel at a promising CAGR of more than 9.50% over the forecast period from 2020 to 2027.. GET SAMPLE COPY @ https://www.reportocean.com/industry-verticals/sample-request?report_id=bw1488. Rising Demand for Hair Loss Treatment Boost Global Alopecia Market. The global alopecia treatment market is largely driven by the rising demand for ...
... or Patterned Hair Loss ,the most common type of genetic hair loss affecting men and women ,is characterized by a process of progressive hair miniaturization whereby large,pigmented terminal hairs are replaced by fine ,colorless short hairs called vellus hairs. Hormone Androgens play a central role in this process of thinning of hair .These type of hairs continue to stay in the scalp however because they are thin and short the affected individuals appear to be bald. CLICK Frequently Asked Questions about Hair Transplant Surgery:. Below are the different patterns of hairloss in our patients based on Norwood classification of Androgenic Alopecia in men and Ludwig classification in women.. MALE PATTERN BALDNESS. ...
Understanding the cause. There are a number of different causes of hair loss and before you start looking around for ways to address the problem, its important that understand the trigger in your particular case.. The most common type of hair loss is male pattern baldness. Around half of men experience this by the time they reach the age of 50 and it is characterised by a receding hairline and thinning hair at the temples and on top of the head. Male pattern baldness is thought to run in families. The problem can also affect women. Female pattern baldness usually results in a thinning of hair on the top of the head and it often gets worse after the menopause.. Another type of hair loss is referred to as telogen effluvium. This typically occurs after a stressful physical event such as childbirth, major surgery or sudden weight loss. It can also be triggered by illnesses or certain medications. Fortunately in these cases, hair tends to grow back after a few months.. Hair loss can be caused by ...
Finasteride is the generic name for the brand name Propecia. It is a hair loss treatment medication that is administered orally. Finasteride 1mg is by far the only treatment for male pattern baldness or androgenic alopecia that has been approved by the Food and Drug Administration of the U.S. Although finasteride 1mg has been in use for many years now, the truth is that the drug was not exactly intended for hair treatment at first. Finasteride 1mg was initially a medication used for treating benign prostatic hyperplasia or abnormal enlargement of the prostate gland in males. However, it was discovered that at low doses, it is able to treat androgenic alopecia.. Since finasteride 1mg has been widely used for several years now and by more than a million men suffering from male pattern baldness, it has proven to be very effective and safe in the treatment of pattern baldness in men of different age groups, race, and ethnicity. Finasteride 1mg can be used alone or in tandem with minoxidil, a drug ...
Many scientists believe that the appropriate dosage of hair vitamins may stop and reverse guy pattern baldness, or MPB. MPB is the man variation of the type of hair reduction well-known as androgenic alopecia. It has been determined that androgenic alopecia counts for 95% of all hair reduction in guys.. The idea that man pattern baldness is countered with all the appropriate hair vitamins is hopeful information indeed for millions of males, because despite the traditional wisdom the wide most of males detest losing their hair as a result of MPB and discover it to be emotionally truly painful. While it is actually true that some males happen to be thus appealing in different methods, or because they happen to have looks that fit hand-in-glove with balding, that they dont care about losing their hair as they age, they are just a really little minority of guys.. Most guys are not the good-looking stars or dont fit the image of the recognized aging genius novelist that are portrayed in the media ...
At the point when a lady encounters male pattern baldness it is harder than it is for most men. In spite of the fact that men are unsettled about the male pattern baldness they have, it appears to remove a bonus from a female. They may endure a misfortune in fearlessness and confidence, and feel less female. In any case, you should not stress you can get the issue of female hormonal male pattern baldness adjusted. First you have to head into the specialist to ensure it is a result of your hormones that you are losing your hair. See when the hormones become out of parity it could cause an excessive amount of DHT to be delivered. At the point when that your hair may get a sign to quit developing. In spite of the fact that it is not so much what you need to occur, so you should figure out how to recover those hormones into request.. At the point when that happens your hair will start to develop back, yet you may need to look out a quarter of a year for it to begin truly developing. Seeing an ...
Are my parents to blame?. Unfortunately, the vast number of people that lose their hair are predestined for the fall! A hereditary condition that develops after puberty is the main culprit. The biology behind this is that androgens (linked to testosterone) stop hair follicles producing hair in a patterned distribution.. This is known as androgenetic alopecia (AGA) or"male pattern baldness". Typically, hereditary or genetic hair loss is better understood in men than in women. "Female pattern baldness" is also affected by androgens, alongside other factors, and is still the subject of research.. What are the other causes of hair loss?. Other causes of hair loss, hair thinning and baldness are less common and include:. thyroid disease. iron deficiency. high fever. surgery or general anaesthesia. childbirth. certain medications. autoimmune diseases (such as lupus, lichen planopilaris, and alopecia areata). Stress is also a factor in alopecia, although it is thought to speed up hereditary hair loss ...
Its inevitable for various people to deal with certain hair problems. One particular common problem is hair loss and the solutions available for it. Here are some myths and facts about hair loss and the corresponding hair transplant that can go along with it.. 1. Im too young to have a hair transplant. The minimum age to have this surgery is to be at least in their 20s, especially for men who have extensive hair loss at this early age due to a strong family history of genetic hair loss. However, most men who seek hair transplant surgery are in their late 30s or in their prime age of 40-50 years.. 2. Hair transplant is only for balding men and not for women. Both men and women suffer from genetic hair loss, we call Male Pattern Hair Loss and Female Pattern Hair Loss. This genetic hair loss, called Androgenetic alopecia in general, is the most common indication for having a hair transplant surgery.. 3. Asians are less likely to need a hair transplant than Caucasians. Androgenetic alopecia ...
Male pattern baldness, also known as androgenetic alopecia, is the most common type of hair loss in men. It by and large follows a typical pattern of receding hairline and hair thinning over the crown area. It is primarily triggered by hormonal and genetic predisposition.
... is a surgical technique that removes hair follicles from one part of the body, called the 'donor site', to a bald or balding part of the body known as the 'recipient site'. The technique is primarily used to treat male pattern baldness. In this minimally invasive procedure, grafts containing hair follicles that are genetically resistant to balding, (like the back of the head) are transplanted to the bald scalp. Hair transplantation can also be used to restore eyelashes, eyebrows, beard hair, chest hair, pubic hair and to fill in scars caused by accidents or surgery such as face-lifts and previous hair transplants. Hair transplantation differs from skin grafting in that grafts contain almost all of the epidermis and dermis surrounding the hair follicle, and many tiny grafts are transplanted rather than a single strip of skin. Since hair naturally grows in groupings of 1 to 4 hairs, current techniques harvest and transplant hair "follicular units" in their natural groupings. ...
The ARTAS System is a robotic surgical hair transplantation system for the treatment of androgenetic alopecia, or male pattern baldness, made by the American company Restoration Robotics, Inc. The device was approved by the Food and Drug Administration (FDA) in 2011 for use in harvesting follicular units from brown-haired and black-haired men. The ARTAS System is designed to facilitate hair restoration using the follicular unit extraction (FUE) technique. The ARTAS System was developed by Restoration Robotics, Inc., a privately held medical device company founded in 2002. ARTAS was introduced at the annual meeting of the International Society of Hair Restoration Surgeons (ISHRS) in 2008, and clinical trials were begun to develop and validate the system. A 510(k) clearance for safety and efficacy from the FDA was granted to Restoration Robotics in April 2011. In 2013, the ARTAS System won the Gold Edison Award in Medicine. Restoration Robotics announced the shipment of its 100th ARTAS System ...
... is the frontotemporal hairline recession and eyebrow loss in postmenopausal women that is associated with perifollicular erythema, especially along the hairline. It is considered to be a clinical variant of lichen planopilaris. There is loss of both terminal and vellus hairs that occurs in a bandlike pattern on the frontotemporal scalp. It is a scarring alopecia that has been associated with a loss of eyebrows, facial papules, glabellar red dots, and prominent venous vasculature in the forehead. Facial hyperpigmentation may occur in dark-skinned patients, if association with lichen planus pigmentosus is present. Frontal Fibrosing Alopecia has been most often reported in post-menopausal women with higher levels of affluence and a negative smoking history. Autoimmune disease is found in 30% of patients. Although the pathogenesis of Frontal Fibrosing Alopecia is poorly understood, autoimmune reaction and hormonal factors may play a role. Perifollicular ...
... , also known as cicatricial alopecia, is the loss of hair which is accompanied with scarring. This is in contrast to non scarring hair loss. It can be caused by a diverse group of rare disorders that destroy the hair follicle, replace it with scar tissue, and cause permanent hair loss. A variety of distributions are possible. In some cases, hair loss is gradual, without symptoms, and is unnoticed for long periods. In other cases, hair loss is associated with severe itching, burning and pain and is rapidly progressive. The inflammation that destroys the follicle is below the skin surface and there is usually no "scar" seen on the scalp. Affected areas of the scalp may show little signs of inflammation, or have redness, scaling, increased or decreased pigmentation, pustules, or draining sinuses. Scarring hair loss occurs in otherwise healthy men and women of all ages and is seen worldwide. It is important to continue to watch for symptoms and signs of active disease during and ...
am new to editing and got a bollocking last time for erasing some guys purile rubbish about hidden memories etc but Later life[edit source , editbeta] Blessed Cecilia Caesarini, who was received by St. Dominic into his new order, in her old age described him as "...thin and of middle height. His face was handsome and somewhat fair. He had reddish hair and beard and beautiful eyes. ...His hands were long and fine and his voice pleasingly resonant. He never got bald, though he wore the full tonsure, which was mingled with a few grey hairs.[15]https://en.wikipedia.org/wiki/St_Dominic what I try to illustrate is that there seems to be something of a species characteristic going on. Male pattern baldness is mostly the result of a genetic event that causes dihydrotestosterone (DHT), a male hormone, to cause the hair follicles to shrivel. The hair produced is progressively smaller, until it is practically invisible (or may disappear completely). It has been speculated that this is an evolutionary event ...
... , also known as 17α-estradiol and sold under the brand names Avicis, Avixis, Ell-Cranell Alpha, and Pantostin, is a weak estrogen and a 5α-reductase inhibitor which is used as a topical medication in the treatment of androgenic alopecia (pattern hair loss) in men and women. It is a stereoisomer of the endogenous steroid hormone and estrogen 17β-estradiol (or simply estradiol). Alfatradiol is used in form of an ethanolic solution for topical application on the scalp. Similarly to other drugs against alopecia, topical or oral, it has to be applied continuously to prevent further hair loss. Regrowth of hair that was already lost is only possible to a limited extent. In general, advanced alopecia does not respond well to medical treatment, which has historically been thought to be a consequence of the hair roots being lost. A university-led study (including several authors who are advisors to companies such as Pfizer) in 103 women comparing alfatradiol to ...
This is a list of 5α-reductase inhibitors (5α-RIs), drugs which inhibit one or more isoforms of the enzyme 5α-reductase. This enzyme is responsible for the conversion of the androgen hormone testosterone into the more potent dihydrotestosterone (DHT) and is essential for the production of neurosteroids like allopregnanolone, tetrahydrodeoxycorticosterone (THDOC), and 3α-androstanediol from progesterone, deoxycorticosterone, and DHT, respectively. 5α-Reductase inhibitors have medical applications in the treatment of benign prostatic hyperplasia, androgenic alopecia (pattern hair loss), and hirsutism (excessive hair growth). 5α-RIs used in medicine include the following: Finasteride (Proscar, Propecia) Dutasteride (Avodart) Epristeride (Aipuliete, Chuanliu) Alfatradiol (Ell-Cranell Alpha, Pantostin) Saw palmetto extract (Permixon) Some of the 5α-RIs in research are as follows: Bexlosteride (LY-191704) Izonsteride (LY-320236) Lapisteride (CS-891) Turosteride (FCE-26073) FCE-28260 MK-386 ...
Hair thinning and baldness cause psychological stress due to their effect on appearance. Although societal interest in appearance has a long history, this particular branch of psychology came into its own during the 1960s and has gained momentum as messages associating physical attractiveness with success and happiness grow more prevalent.[10]. The psychology of hair thinning is a complex issue. Hair is considered an essential part of overall identity: especially for women, for whom it often represents femininity and attractiveness. Men typically associate a full head of hair with youth and vigor. Although they may be aware of pattern baldness in their family, many are uncomfortable talking about the issue. Hair thinning is therefore a sensitive issue for both sexes. For sufferers, it can represent a loss of control and feelings of isolation. People experiencing hair thinning often find themselves in a situation where their physical appearance is at odds with their own self-image and commonly ...
Hair thinning and baldness cause psychological stress due to their effect on appearance. Although societal interest in appearance has a long history, this particular branch of psychology came into its own during the 1960s and has gained momentum as messages associating physical attractiveness with success and happiness grow more prevalent.[10] The psychology of hair thinning is a complex issue. Hair is considered an essential part of overall identity: especially for women, for whom it often represents femininity and attractiveness. Men typically associate a full head of hair with youth and vigor. Although they may be aware of pattern baldness in their family, many are uncomfortable talking about the issue. Hair thinning is therefore a sensitive issue for both sexes. For sufferers, it can represent a loss of control and feelings of isolation. People experiencing hair thinning often find themselves in a situation where their physical appearance is at odds with their own self-image and commonly ...
... (diphencyprone) is a topically administered experimental drug intended for treating alopecia areata and alopecia totalis. Topical immunotherapy using diphenylcyclopropenone may also be an effective treatment option for recalcitrant warts. It is not approved by either the Food and Drug Administration or the European Medicines Agency. Diphenylcyclopropenone acts as a local irritant, triggering a local sensitization. It triggers an immune response that opposes the action of the autoreactive cells that otherwise cause hair loss. A study of 41 alopecia areata patients showed significant hair regrowth in 40% at 6 months, being sustained in two thirds of these after a 12-month-follow up-period. In a 2002 study for the treatment of warts, the responders consisted of 135 individuals (87.7%) that had complete clearance of warts. Reported adverse effects were local and included with pruritus (itching) (15.6%), with blistering (7.1%), and with eczematous reactions ...
... (from the Latin glaber meaning "bald", "hairless", "shaved", "smooth") is the technical term for a lack of hair, down, setae, trichomes or other such covering. A glabrous surface may be a natural characteristic of all or part of a plant or animal, or be due to loss because of a physical condition, such as alopecia universalis in humans, which causes hair to fall out or not regrow. Humans may also intentionally remove some or all of their body hair for a variety of cultural reasons. Glabrousness or otherwise, of leaves, stems, and fruit is a feature commonly mentioned in plant keys; in botany and mycology, a glabrous morphological feature is one that is smooth and may be glossy. It has no bristles or hair-like structures such as trichomes. In anything like the zoological sense, no plants or fungi have hair or wool, although some structures may resemble such materials. The term "glabrous" strictly applies only to features that lack trichomes at all times. When an organ bears trichomes ...
... is a rare, autosomal recessive disorder that causes severe growth retardation, and has been observed fewer than 30 times before 2011. GAPO is an acronym that encompasses the predominant traits of the disorder: growth retardation, alopecia, pseudoanodontia (teeth failing to emerge from the gums), and worsening optic atrophy in some subjects. Other common symptoms include premature aging, large, prominent foreheads, and delayed bone aging. GAPO syndrome typically results in premature death around age 30-40, due to interstitial fibrosis and atherosclerosis. One of the principle symptoms of GAPO syndrome is growth retardation, caused by slow skeletal formation and results in individuals being below average height. Alopecia, or hair loss, is another key indication of GAPO syndrome. Their hair is typically thinly dispersed, and fragile, which often leads to baldness later in life. Similarly, tooth growth is stunted, with teeth failing to emerge form the gums or otherwise ...
Ang pagkakalbo o pagkapanot ay ang paglulugas ng buhok. Sa medisina, tinatawag ang ganitong kalagayan bilang alopesya, mula sa Ingles na alopecia.[1] ...
Alopecia mucinosa (also known as "Follicular mucinosis," "Mucinosis follicularis,",[1] "Pinkus follicular mucinosis,"[1] and " ... Retrieved from "https://en.wikipedia.org/w/index.php?title=Alopecia_mucinosa&oldid=782222140" ...
Treatments and Tools for Alopecia areata. Find Alopecia areata information, treatments for Alopecia areata and Alopecia areata ... MedHelps Alopecia areata Center for Information, Symptoms, Resources, ... Hi, is this Alopecia areata or something else? I have two spots, they are tiny but im hopp... ... Hi i was diagnosed of alopecia arteata 6 months ago .. but i have ben having it since octob... ...
Alopecia -The loss of hair, or baldness. Dopamine -A neurotransmitter made in the brain that is involved in many brain ... First described in 1889, trichotillomania is a psychiatric disorder, the result of which is alopecia or hair loss, caused by ... The pattern of alopecia in trichotillomania varies among patients and the degree of hair loss will range from a barely ... If the hair pulling continues for long periods without treatment, the alopecia may be permanent. ...
To date, only two products are FDA approved to retard or reverse male pattern alopecia: minoxidil (Rogaine) and finasteride ( ...
Signs and Symptoms of Alopecia. A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References.. Signs ...
Clinical diagnosis of alopecia areata or other non AGA forms of alopecia. Scalp hair loss on the treatment area, due to disease ... Alopecia. Alopecia Areata. Hypotrichosis. Hair Diseases. Skin Diseases. Pathological Conditions, Anatomical. Pharmaceutical ... A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution. The safety and ... An Open-Label Safety, Tolerability, and Efficacy Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI- ...
... whether caused by alopecia areata, trichotillomania, chemotherapy, or any other cause. ... r/alopecia: A place to share information and offer support for people with hair loss of all types and severity, ... Im 22, have Alopecia and its caused me to lose all the hair on my own head. Could this be the onset of Alopecia?. ... My grandmother had alopecia and lost all of her hair when she was 18. I think I might have the same. My hair is constantly ...
Be More Chill star Lauren Marcus on her alopecia diagnosis: Im trying to find the best in it. Actress Lauren Marcus shares ... the story of her alopecia areata diagnosis - just as her show, Be More Chill, makes it big. ...
a b c d e f g h i Zoe Diana Draelos (August 30, 2007), Alopecia Areata Archived 2007-12-08 at the Wayback Machine.. MedicineNet ... Trichotillomania, alopecia mucinosa, postpartum alopecia[1]. Treatment. Sunscreen, head coverings to protect from sun and cold[ ... Alopecia areata and alopecia barbae have been identified by some as the biblical nethek condition that is part of the greater ... a b c d e f Alopecia Areata at Merck Manual of Diagnosis and Therapy Professional Edition ...
The diagnosis of alopecia can be challenging. Usually the physician needs clinicopathologic correlation to achieve the correct ... Alopecia syphitica - report of a patient with secondary syphilis presenting as moth-eaten alopecia and a review of its common ... Psoriatic alopecia/alopecia areata-like reactions secondary to anti-tumor necrosis factor-alpha therapy: a novel cause of ... Torres F, Tosti A. Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia. Semin Cutan Med Surg. 2015;34: ...
Finally, when I was almost 12, I was diagnosed with alopecia areata. Doctors believe alopecia areata is an autoimmune disease ... alopecia areata.. Her classmates needed no explanation since it was obvious that the girl had lost her eyelashes, eyebrows, ...
Fundraise or donate to Alopecia UK with JustGiving, the worlds leading online fundraising platform, helping charities to make ... Join the Alopecia UK community. Alopecia UK is a registered charity working to improve the lives of those affected by alopecia ... Alopecia UK. We have Support, Awareness & Research aims to improve the lives of those with alopecia. ... "we recently held a raffle to help one of our colleagues who suffers from Alopecia to help her with treatment for hair ...
The Australia Alopecia Areata Foundation exists to improve the lives of people living with Alopecia Areata and their families. ...
Androgenetic alopecia is a common form of hair loss in both men and women. Explore symptoms, inheritance, genetics of this ... Androgenetic alopecia in women rarely leads to total baldness.. Androgenetic alopecia in men has been associated with several ... Yazdan P. Update on the genetics of androgenetic alopecia, female pattern hair loss, and alopecia areata: implications for ... Androgenetic alopecia is a common form of hair loss in both men and women. In men, this condition is also known as male-pattern ...
androgenic alopecia is a genetic condition that can affect both men and women. men with this condition, called male pattern ... What is androgenic alopecia?. ANSWER Androgenic alopecia is a genetic condition that can affect both men and women. Men with ...
Female androgenetic alopecia is the most common form of non-scarring alopecia in women. Review its etiology, differential ... FAGA female androgenetic alopecia, FAPD fibrosing alopecia in pattern distribution, FFA frontal fibrosing alopecia, T:V ... Female androgenetic alopecia (FAGA) is the most common form of non-scarring alopecia in women, characterized by diffuse hair ... Table 1. Main features of FAGA and cicatricial alopecias with a female pattern distribution FAGA. FAPD. CPHL. CCCA. FFA. ...
Alopecia areata may be hereditary and isnt contagious. ... Alopecia Areata. *Alopecia areata facts. *What is alopecia ... Read about alopecia areata causes, symptoms (balding), diagnosis, and hair loss treatment (shampoo). ... Top Alopecia Areata Related Articles. *. Alopecia Areata (Nails) Picture. Pitting in organized transverse rows giving the nail ... National Alopecia Areata Foundation. Spano, Frank, and Jeff C. Donovan. "Alopecia Areata: Part 1: Pathogenesis, Diagnosis, and ...
Alopecia areata is a form of hair loss thats triggered by your immune system mistakenly viewing hair follicles as threats to ... HealthDay News) -- Alopecia areata is a form of hair loss thats triggered by your immune system mistakenly viewing hair ... home/skin center/ skin a-z list/ health tip: understanding alopecia areata article ... Do certain diseases or conditions raise a persons risk for developing alopecia areata? ...
Alopecia areata, a fairly common disorder of unknown cause characterized by sharply outlined patches of sudden complete ... Other articles where Alopecia areata is discussed: baldness: ... Alopecia areata. dermatology. THIS IS A DIRECTORY PAGE. ... Alopecia areata, a fairly common disorder of unknown cause characterized by sharply outlined patches of sudden complete ...
... It only rarely occurs on the head. When it does, it usually occurs on the scalp of a child who has a ... Alopecia (meaning hair loss) is hardly ever due to an infection and is therefore, generally speaking, not a contagious ... Is alopecia a contagious condition? Could it be caught from someone who has had it? ... Do you think my alopecia could be due to a hormonal problem? ... Alopecia areata. Are these oestrogen patches causing my hair ...
alopecia [ˌ ləpi ʃ ə]. noun loss of hair, esp. on the head; baldness. [ETYMOLOGY: 14th Century: from Latin, from Greek ...
Alopecia is the medical term for hair loss. There are several patterns of natural and disease related hair loss. Hair loss may ... Scarring alopecia. Also called cicatricial alopecia, this type of alopecia refers to permanent hair loss caused by rare ... Alopecia Types. There a number of different types of alopecia and some of the more common forms are described in more detail ... www.niams.nih.gov/health_info/alopecia_areata/alopecia_areata_ff.pdf ...
Hair Follicle Sebaceous Gland Lichen Planus Mycosis Fungoides Alopecia Areata These keywords were added by machine and not by ... Smoller B.R., Hiatt K.M. (2010) Alopecias. In: Inflammatory Dermatoses: The Basics. Springer, Boston, MA. * DOI https://doi.org ...
  • Presence of follicles without vellus hairs marks the end stages of traction alopecia. (livestrong.com)
  • With psychogenic alopecia it is common to find broken, barbered hair shafts rather than intact hairs with the root attached. (petplace.com)
  • Also called seasonal flank alopecia, the condition occurs more frequently in certain breeds and in regions with scant sunlight. (wisegeek.com)
  • Flank alopecia is also known as canine recurrent flank alopecia (CRFA), canine idiopathic cyclic flank alopecia, cyclic flank alopecia, cyclic follicular dysplasia and seasonal flank alopecia. (petplace.com)
  • Seasonal flank alopecia Seasonal flank alopecia (Canine Recurrent Flank Alopecia - CRFA) is a cyclical or episodic follicular disease that occurs when daylight begins to shorten (fall of the year) with progression through the winter. (dogclub.co.uk)
  • Seasonal flank alopecia has been reported in numerous breeds but is recognized most frequently in Boxers, English Bulldogs, Airedales, Schnauzers, Doberman Pinschers and Bouvier des Flanders. (dogclub.co.uk)
  • In dogs with seasonal flank alopecia this cycle is believed to be disordered. (dogclub.co.uk)
  • In cases of alopecia areata, hair will tend to pull out more easily along the edge of the patch where the follicles are already being attacked by the body's immune system than away from the patch where they are still healthy. (wikipedia.org)
  • As a first option for mild cases of alopecia barbae, you will be prescribed corticosteroid cream or ointment, which is applied directly to the patches affected. (ehow.co.uk)
  • Furthermore, cases of alopecia involving only the eyelashes are extremely rare, the journal reports. (livestrong.com)
  • In all cases of alopecia, the hair follicles remain alive and have the potential to resume normal hair production when they receive the appropriate signal. (headcovers.com)
  • This plastic cone collar will prevent compulsive self-grooming, so psychogenic alopecia is ruled out. (vetinfo.com)
  • The new definition helps us better understand and determine the cause, course, and therapy of the feline equivalent, psychogenic alopecia. (petplace.com)
  • Medical conditions that can be confused with psychogenic alopecia and must be ruled out before the diagnosis can be confirmed. (petplace.com)
  • For those familiar with psychogenic alopecia, the appearance is fairly typical, and parasites are fairly easy to detect, but confusion is possible in some cases unless a careful inspection is made. (petplace.com)
  • Generally, psychogenic alopecia does not lead to serious health consequences or a decreased lifespan. (wikipedia.org)
  • Strong evidence of genetic association with increased risk for alopecia areata was found by studying families with two or more affected members. (wikipedia.org)
  • van der Steen P, Traupe H, Happle R, Boezeman J, Sträter R, Hamm H. The genetic risk for alopecia areata in first degree relatives of severely affected patients. (medscape.com)
  • There a number of different types of alopecia and some of the more common forms are described in more detail below. (news-medical.net)
  • Now, in this beautifully photographed collection, Graham provides a thorough guide to the different types of alopecia and its triggers and treatments, also sharing numerous stories of those affected. (amazon.com)
  • Alopecia areata most often is asymptomatic, but some patients (14%) experience a burning sensation or pruritus in the affected area. (medscape.com)
  • In about 20 percent of cases, a person with the condition also has a family member who has alopecia, the American Academy of Dermatology reports. (livestrong.com)
  • What are the signs and symptoms of the different patterns of alopecia areata? (medicinenet.com)
  • A syndrome characterized by bilateral granulomatous UVEITIS with IRITIS and secondary GLAUCOMA, premature ALOPECIA, symmetrical VITILIGO, poliosis circumscripta (a strand of depigmented hair), HEARING DISORDERS, and meningeal signs (neck stiffness and headache). (bioportfolio.com)
  • Diagnosis and treatmentHistory, breed, clinical signs and elimination of endocrine causes of symmetrical alopecia (hypothyroidism, hyperadrenocorticism) place CRFA high on the differential diagnoses list. (dogclub.co.uk)
  • A systematic MEDLINE search could not find any study with sufficient validity to provide scientific evidence of benefit with complementary and alternative medicine therapies for alopecia areata. (medscape.com)
  • This article reviews the research into the psychological impact of alopecia. (bmj.com)
  • FDA is interested in obtaining patient input on the impact of alopecia areata, including on daily life, patient views on treatment approaches, and decision factors taken into account when selecting a treatment. (fda.gov)
  • To better comprehend the impact of alopecia, it is important to understand the normal process of hair growth. (uspharmacist.com)
  • Parasites, hormone problems and allergies are all common causes of alopecia in dogs. (pdsa.org.uk)
  • When the plugs persist, they are obvious features on healed, hairless patches of alopecia mucinosa. (medscape.com)
  • It's rare for alopecia to be permanent, with the correct treatment, it's likely your dog's coat will regrow. (pdsa.org.uk)
  • Some dogs develop harmless patches of alopecia in the autumn that don't regrow for 6-12months. (pdsa.org.uk)